Drug
Ptc124
Ptc124: highest development phase Phase 2, developed by PTC Therapeutics. 2 trial records tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- PTC Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| PTC124 NCT00264888 | Phase 2 | Duchenne Muscular Dystrophy |
| PTC124 NCT00351078 | Phase 2 | Cystic Fibrosis |
Latest
No recent events.
Follow Ptc124 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.